Appointments

Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Cancer Imaging Program Fellowships

    The Cancer Imaging Program (CIP) Fellowship at Dana-Farber Cancer Institute provides extensive experience in body imaging, including MRI, CT, PET-CT, and US in adult patients with cancer. Dana-Farber Cancer Institute (DFCI) is a Harvard Medical School Teaching affiliate and provides adult clinical care jointly with Brigham and Women's Hospital (BWH).

    Cancer Imaging Program Fellowship

    Rotation overview
    • Depending on the chosen track (general Cancer Imaging or PET-CT): 80% time will be spent reading cancer imaging studies with our CT, MR, U/S, Mammo, or PET-CT.
    • Approximately 20% of the Fellow's time can be dedicated to research, assuming that a detailed research project outline has been presented and approved by an attending radiologist as the project mentor. Research milestone schedules will be clearly articulated and research progress is closely monitored.
    • Four weeks of the CIP Fellowship is designated elective time, which may be spent on approved research projects or in other radiology disciplines.
    • On-call responsibilities consist of weekend day coverage.
    Eligibility

    U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified, trained in radiology and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with fellowship regulations as provided by the Department of Radiology at BWH.

    Teaching/conference responsibilities

    In addition to weekly MRI/CT/US/PET-CT case conferences, there is an introductory lecture series and monthly lecture series given by Radiology Attending Physicians, Fellows, and Clinical Oncologists. This is in addition to ongoing one-on-one teaching throughout the day.

    Fellowship supervision and evaluation

    Imaging Fellows will receive continuous on-site training, teaching, and feedback. Dr. Fiona Fennessy, Director of the Dana-Farber Imaging Fellowship Program, and Dr. Katherine Krajewski, Co-Director, will evaluate the each of the Fellow's performance.

    Equipment and resources

    State-of-the-art equipment includes 64-slice CT, 1.5-T and 3-T MRI, PET-CT, digital radiography, US and gamma camera systems. Dana-Farber also serves as a core imaging analysis laboratory for imaging studies performed in the context of local, national, and global clinical trials.

    Application procedure

    Applicants should send their C.V., personal statement, USMLE scores, and three reference letters (sent directly by the referees) to the address below. Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations.

    Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director
    Katherine M. Krajewski, MD, Co-Program Director
    Dana-Farber Cancer Institute, Department of Imaging (DL101)
    450 Brookline Avenue
    Boston, MA 02215
    Attention: Erin Foley

    Phone: 617-632-4891
    Fax: 617-582-8574
    Email: erinm_foley@dfci.harvard.edu

    Translational Cancer Imaging Clinical Fellowship

    The Translational Cancer Imaging Fellowship is designed to teach trainees how imaging is being used in the context of the progress made in molecular medicine. Trainees will gain expertise in the understanding of the molecular mechanisms of cancer, the molecular-targeted drugs used to treat it, and the multiparametric anatomic and functional imaging tools available to diagnose cancer and evaluate responses to treatment.

    Particular emphasis is placed on the use of imaging as a biomarker of response to treatment, the use and interpretation of tumor metrics, the comparative effectiveness of imaging procedures, the quantitation of imaging results, and the validation of imaging analysis methods.

    Rotation overview
    • Four months in nuclear medicine, including training in general nuclear medicine, cardiac imaging, and PET-CT with FDG, as well as novel PET tracers of cell proliferation, hypoxia, and apoptosis.
    • Four months in cross-sectional imaging, including advanced applications with 64-slice CT, and 3T MRI.
    • Four months in the design and implementation of a clinical trial that includes imaging as a primary endpoint. The trainee will learn to oversee all aspects of a clinical trial, which includes: concept development, protocol writing, protocol submission for institutional review board (IRB) approval, participant recruitment, informed consent, data collection, analysis, interpretation, and presentation of these data.
    Eligibility

    U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified, trained in radiology and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with the fellowship regulations as provided by the Department of Radiology at BWH and the BWH GME office.

    Application procedure

    Applicants should send C.V. and three reference letters (sent directly by the referees) to:

    Annick D. Van den Abbeele, MD, Chief Department of Imaging
    Dana-Farber Cancer Institute
    Department of Imaging
    450 Brookline Avenue
    Boston MA 02215
    Attention: Erin Foley

    Phone: 617-632-4891
    Fax: 617-582-8574
    Email: erinm_foley@dfci.harvard.edu

    Nuclear Oncology/PET-CT Clinical Fellowship

    Dana-Farber Cancer Institute/Brigham and Women's Hospital, Nuclear Medicine Oncology Program is accepting applications from MD/MD-PhD affiliates for a one-year Nuclear Oncology/PET-CT Fellowship with the opportunity to extend to a second year.

    Dana-Farber Cancer Institute is designated a comprehensive cancer center by the National Cancer Institute. The clinical fellowship will provide physicians with advanced clinical imaging training in oncology with a focus on PET-CT and cross-sectional imaging. Fellows also have the opportunity to participate in various clinical research projects. Major areas of interest include molecular imaging, evaluation of molecularly-targeted drugs, and new PET radiopharmaceuticals. The clinical research practice is supported by a tumor metrics core laboratory for local, national, and global trials. Dana-Farber Cancer Institute is an affiliate of the Harvard Medical School Joint Program in Nuclear Medicine.

    Eligibility

    Completion of the USMLE parts I, II, and III, and American Board of Radiology (ABR) and/or American Board of Nuclear Medicine (ABNM) eligible or certified.

    Application procedure

    Interested applicants should send a letter of intent, their C.V., and the names of three contacts for references, or three reference letters to:

    Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director
    Katherine M. Krajewski, MD, Co-Program Director
    Dana-Farber Cancer Institute, Department of Imaging (DL101)
    450 Brookline Ave.
    Boston, MA 02115
    Attention: Erin Foley

    Phone: 617-632-4891
    Fax: 617-582-8574
    Email: erinm_foley@dfci.harvard.edu

  •   Email
  •   Print
  •   Share
dana farber logo

450 Brookline Avenue
Boston, MA 02215

Call us toll-free: 866-408-DFCI (3324)

Connect with us
award

Dana-Farber/Brigham and Women’s Cancer Center is ranked #4 nationally and the best in New England.

award

Dana-Farber/Boston Children's is ranked the #1 pediatric cancer center.

Sign-up for newsletters